Skip to main content
. 2023 Jun 15;13(6):2234–2253.

Figure 10.

Figure 10

K-M survival analysis in single PR+ patients (stratified by endocrine therapy). K-M: Kaplan-Meier; HR: hazard ratio; CI: confidence interval; initial endocrine therapy: 5 years of treatment with tamoxifen or aromatase inhibitors; intensified endocrine therapy: 5 years of tamoxifen or aromatase inhibitor therapy followed by either its continuation or concomitant ovarian function inhibitor therapy.